Terry W Moody Selected Research

Terry W Moody Research Topics

Disease

31	Neoplasms (Cancer) 07/2023 - 10/2002
29	Lung Neoplasms (Lung Cancer) 07/2023 - 04/2002
14	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2022 - 04/2002
8	Breast Neoplasms (Breast Cancer) 07/2023 - 10/2002
5	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 11/2019 - 01/2003
5	Neuroendocrine Tumors (Neuroendocrine Tumor) 11/2019 - 01/2003
4	Carcinogenesis 03/2009 - 05/2002
2	Central Nervous System Diseases (CNS Diseases) 01/2021 - 02/2011
2	Neoplasm Metastasis (Metastasis) 01/2017 - 05/2005
2	Adenocarcinoma 03/2009 - 07/2002
2	Adenoma (Adenomas) 09/2007 - 07/2002
1	Migraine Disorders (Migraine) 01/2021
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2021
1	Rheumatoid Arthritis 01/2021
1	Neuroblastoma 02/2016
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2016
1	Schizophrenia (Dementia Praecox) 02/2011

Drug/Important Bio-Agent (IBA)

14	Peptides (Polypeptides)IBA 07/2023 - 09/2006
13	Tyrosine (L-Tyrosine)FDA Link 07/2023 - 05/2002
12	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021 - 11/2002
12	BombesinIBA 01/2021 - 01/2003
10	Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA 08/2021 - 11/2002
10	Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA 01/2021 - 10/2002
10	Bombesin Receptors (Bombesin Receptor)IBA 01/2021 - 08/2003
9	NeurotensinIBA 07/2023 - 05/2002
8	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 07/2023 - 01/2011
8	ErbB Receptors (EGF Receptor)IBA 07/2023 - 07/2010
6	Tyrosine Kinase InhibitorsIBA 07/2023 - 06/2012
6	Vasoactive Intestinal Peptide Receptors (Vasoactive Intestinal Peptide Receptor)IBA 09/2007 - 10/2002
5	NeuropeptidesIBA 01/2020 - 01/2003
5	Phosphatidylinositols (Phosphatidylinositol)IBA 11/2019 - 01/2012
4	Gefitinib (Iressa)FDA Link 07/2023 - 06/2012
4	bombesin receptor subtype 3IBA 01/2018 - 08/2010
4	Cholecystokinin (Pancreozymin)IBA 01/2016 - 12/2006
3	Proteins (Proteins, Gene)FDA Link 07/2023 - 07/2002
3	Pituitary Adenylate Cyclase-Activating Polypeptide ReceptorsIBA 01/2021 - 06/2012
3	Messenger RNA (mRNA)IBA 12/2019 - 01/2004
3	Cytotoxins (Cytolysins)IBA 01/2018 - 09/2006
3	Epidermal Growth Factor (EGF)IBA 01/2017 - 07/2010
3	Glucose (Dextrose)FDA LinkGeneric 02/2011 - 10/2002
3	CarcinogensIBA 03/2009 - 07/2002
3	Gastrin-Releasing PeptideIBA 02/2008 - 06/2005
3	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 09/2007 - 05/2004
3	CamptothecinIBA 09/2007 - 05/2004
2	Phosphotransferases (Kinase)IBA 07/2023 - 10/2019
2	SR 48692IBA 07/2023 - 03/2014
2	Amino Acids FDA Link 07/2023 - 12/2019
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 07/2023 - 11/2019
2	Endothelins (Endothelin)IBA 01/2021 - 01/2017
2	Neurotensin Receptors (Neurotensin Receptor)IBA 12/2019 - 05/2002
2	Peptide Receptors (Peptide Receptor)IBA 11/2019 - 09/2016
2	Cell Surface ReceptorsIBA 11/2019 - 01/2018
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 03/2018 - 03/2009
2	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2018 - 09/2005
2	Somatostatin Receptors (Somatostatin Receptor)IBA 09/2016 - 01/2011
2	Cholecystokinin Receptors (Cholecystokinin Receptor)IBA 01/2016 - 07/2015
2	GastrinsIBA 01/2016 - 07/2015
2	Metalloproteases (Metalloproteinases)IBA 07/2015 - 08/2011
2	Focal Adhesion Protein-Tyrosine KinasesIBA 01/2012 - 05/2002
2	neuromedin BIBA 07/2010 - 02/2008
2	S-sulindacIBA 05/2010 - 03/2009
2	2- ((2,6- dichlorophenyl)amino)benzeneacetic acid 4-(3H-1,2-dithiol-3-thione-5-yl)phenyl esterIBA 05/2010 - 03/2009
2	Urethane (Ethyl Carbamate)IBA 09/2007 - 07/2002
2	ThymalfasinIBA 09/2007 - 05/2002
2	AntigensIBA 09/2007 - 01/2004
2	Peptide Hormones (Polypeptide Hormones)IBA 09/2006 - 08/2004
2	BromidesIBA 09/2006 - 05/2004
2	Transforming Growth Factor beta (TGF-beta)IBA 01/2006 - 07/2002
2	PD 176252IBA 01/2006 - 08/2003
2	Type I Vasoactive Intestinal Polypeptide ReceptorsIBA 12/2004 - 01/2004
2	(VIP-neurotensin) hybrid antagonistIBA 01/2004 - 01/2003
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2003 - 11/2002
1	Neuregulin-1 (Neuregulin 1)IBA 07/2023
1	Trastuzumab (Herceptin)FDA Link 07/2023
1	Monoclonal AntibodiesIBA 07/2023
1	NeuregulinsIBA 08/2021
1	Therapeutic UsesIBA 01/2021
1	Retinaldehyde (Retinal)IBA 03/2018
1	AntioxidantsIBA 03/2018
1	nitroxylIBA 03/2018
1	Octreotide (Sandostatin)FDA LinkGeneric 01/2018
1	Growth Factor ReceptorsIBA 01/2018
1	CalciumIBA 01/2018
1	Type C PhospholipasesIBA 01/2018
1	AntibodiesIBA 01/2016
1	Cholecystokinin B ReceptorIBA 01/2016
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2016
1	Superoxides (Superoxide)IBA 07/2015
1	1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium SaltIBA 07/2015
1	PD 134308IBA 07/2015
1	Neurotransmitter Agents (Neurotransmitter)IBA 07/2015
1	N- (2(R)- 2- (hydroxamidocarbonylmethyl)- 4- methylpentanoyl)- L- tryptophan methylamideIBA 07/2015
1	Sincalide FDA Link 07/2015
1	Gastrointestinal Hormones (Hormones, Gastrointestinal)IBA 07/2015
1	gastrin 17 (G 17)IBA 07/2015
1	PaxillinIBA 01/2012
1	Oxygen (Dioxygen)IBA 08/2011
1	Neuroprotective AgentsIBA 02/2011

Therapy/Procedure

2	Therapeutics 01/2021 - 06/2005
2	Lasers (Laser) 01/2004 - 07/2002